EMILY LONGHENRY: Open Payments
NPI 1730339417 · PLATTEVILLE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$731 in 28 payments from 8 companies in 2025. Trend: 2023 $638 · 2024 $897 · 2025 $731
Food & beverage: $731
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $247 |
| Lundbeck LLC | 7 | $136 |
| Neurocrine BioSciences, Inc. | 2 | $121 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| E.R. Squibb & Sons, L.L.C. | 2 | $46 |
| Axsome Therapeutics, Inc. | 1 | $43 |
| Alkermes, Inc. | 2 | $39 |
Products named: VRAYLAR, REXULTI, INGREZZA, TRINTELLIX, COBENFY, Auvelity, LYBALVI.
Industry payments across WI — which companies pay providers there.
